Watch Ticker

Oculis Holding AG Ordinary shares

Go to Oculis Holding AG Ordinary shares Website

$17.95

0.11 (0.62%)

Live

Previous Close

$17.84

Day Range

$17.83 - $17.95

Previous Day Range

$17.75 - $18

Market Cap

$910.4 million USD

Day Vol.

5092

Previous Day Vol.

9778

Currency

USD

Primary Exchange

Nasdaq

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Riad Sherif, M.D., Chief Executive Officer - Oculis Upsized Loan Facility to Access up to CHF 100 million

Oculis Holding AG has amended its loan facility with BlackRock, securing up to CHF 100 million in borrowing capacity to support ongoing clinical trials and product development across three core assets in ophthalmic and neuro-ophthalmic diseases.

Related tickers: OCS, OCSAW.

Read Full Article

Riad Sherif, M.D., Chief Executive Officer - Oculis Upsized Loan Facility to Access up to CHF 100 million

Related tickers: OCS, OCSAW.

Read Full Article

Trending Tickers

Please sign in to view